EAP facilitates patient access, in exceptional circumstances, to drugs approved for sale in Canada but not listed on the ODB Formulary, or in situations where Formulary drugs were ineffective or not tolerated, or where no listed alternative was available, the physician must submit a written request and provide the full detail of the patient's case, the drug is usually approved for a period of one year